These independent CMEactivities are supported by an educational grant from Onyx Pharmaceuticals, an Amgen subsidiary.



Clinical Context:
Multiple Myeloma
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List
Chair
faculty image
Noopur Raje, MD
  • Director, Center for Multiple Myeloma
  • MGH Cancer Center
  • Massachusetts General Hospital
  • Boston, Massachusetts

  • Curriculum In Context: Multiple Myeloma is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple myeloma. The curriculum includes six case studies at the point of care, a webcast, and MedPage Today meeting coverage that will report on cutting-edge news as it breaks from the 56th American Society of Hematology Annual Meeting.
  • Increase awareness and understanding of multiple myeloma, including its epidemiology, morbidity, and mortality.
  • Apply evidence-based strategies for the diagnosis, risk stratification, and treatment of multiple myeloma.
  • Target Audience

    This series of activities is designed for hematologists, oncologists, primary care physicians, internists, family practice practitioners, nurses, nurse practitioners, physician assistants and pharmacists who treat patients with multiple myeloma.

     

    Activity Goal

    The goal of this program is to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple myeloma.